Loading patent…
AssigneePharmacia Corporation
InventorsSteven P. Pulaski, Susan Kundel
Estimating the term…
A method of treating, preventing, or inhibiting pain, inflammation or inflammation-associated disorder in a subject in need of such treatment or prevention provides for treating the subject with chondroitin sulfate and a cyclooxygenase-2 selective inhibitor, or a prodrug thereof, wherein the amount of chondroitin sulfate and the amount of a cyclooxygenase-2 selective inhibitor or a pharmaceutically acceptable salt or prodrug thereof together constitute a pain or inflammation suppressing treatment or prevention effective amount. Glucosamine can optionally be present. Compositions that contain the combination of chondroitin sulfate and cyclooxygenase-2 selective inhibitor and, optionally, the glucosamine, are disclosed, as are pharmaceutical compositions.
A method for the treatment, prevention, or inhibition of pain, inflammation or inflammation-associated disorder in a subject in need of such treatment, prevention, or inhibition, comprising administering chondroitin sulfate and a cyclooxygenase-2 selective inhibitor or prodrug thereof to the subject.
A method of treating or preventing a cyclooxygenase-2 mediated disorder in a subject, said method comprising treating the subject having or susceptible to said disorder with a therapeutically-effective amount of a combination of chondroitin sulfate and a cyclooxygenase-2 selective inhibitor.
A method for the treatment of a subject that has need of the treatment or prevention of disorders having an inflammatory component, the method comprising administering to the subject a therapeutically effective dose of chondroitin sulfate and cyclooxygenase-2 selective inhibitor or a pharmaceutically acceptable salt or prodrug thereof.
A composition for the treatment, prevention, or inhibition or pain, inflammation, or inflammation-associated disorder comprising chondroitin sulfate and a cyclooxygenase-2 selective inhibitor or prodrug thereof.
A pharmaceutical composition comprising chondroitin sulfate;
A kit that is suitable for use in the treatment, prevention or inhibition of pain, inflammation or inflammation-associated disorder, the kit comprises a first dosage form comprising chondroitin sulfate and a second dosage form comprising a cyclooxygenase-2 selective inhibitor or prodrug thereof, in quantities which comprise a therapeutically effective amount of the compounds for the treatment, prevention, or inhibition of pain, inflammation or inflammation-associated disorder.
Dependencies are inferred from the claim text.